Back pain is the second leading cause of disability among American adults and is currently treated either with conservative therapy or interventional pain procedures. [pdf-embedder url="https://www.nsorm.com/wp-content/uploads/2018/07/PRP-and-Stem-Cells-in-Chronic-Low-Back-Pain-May-2017.pdf" title="PRP and Stem Cells in Chronic Low Back Pain May 2017"]
Adipose tissue-derived mesenchymal stem cells (AT-MSCs) offer potential as a therapeutic option for chronic discogenic low back pain (LBP) because of their immunomodulatory functions and capacity for cartilage differentiation. The goal of this study was to assess the safety and tolerability of a single intradiscal implantation of combined AT-MSCs and hyaluronic acid (HA) derivative in [...]
Adipose tissue-derived mesenchymal stem cells (AT-MSCs) offer potential as a therapeutic option for chronic discogenic low back pain (LBP) because of their immunomodulatory functions and capacity for cartilage differentiation. The goal of this study was to assess the safety and tolerability of a single intradiscal implantation of combined AT-MSCs and hyaluronic acid (HA) derivative in [...]